neostigmine has been researched along with Anxiety in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fogaça, MV | 1 |
Fedoce, AG | 1 |
Ferreira-Junior, NC | 1 |
Guimarães, FS | 1 |
Resstel, LB | 1 |
Lange, MJ | 1 |
2 other studies available for neostigmine and Anxiety
Article | Year |
---|---|
Involvement of M1 and CB₁ receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex.
Topics: Animals; Anxiety; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Injections, Intravent | 2016 |
Cholinesterase inhibitors in myasthenia gravis.
Topics: Adult; Anxiety; Cholinesterase Inhibitors; Edrophonium; Female; Humans; Myasthenia Gravis; Neostigmi | 1966 |